Structural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12441 Parklawn Drive, Rockville, MD 20852, USA.
Sci Signal. 2012 May 8;5(223):pe11.
Knowledge about how Toll-like receptors (TLRs) recognize pathogenic ligands is critical to understanding how these receptors are activated and to designing therapeutic compounds that target this family of receptors for inflammatory diseases. The crystal structure of TLR5 in complex with its bacterial ligand flagellin revealed that the ligand-binding mode for TLR5 is distinct from that of previously characterized TLRs. Nevertheless, like other TLRs, TLR5 forms a dimer in response to ligand binding. This work contributes to our current knowledge of TLR function and further demonstrates the ability of TLRs to couple versatile ligand recognition to a conserved receptor signaling mechanism.
关于 Toll 样受体(TLRs)如何识别病原体配体的知识对于理解这些受体如何被激活以及设计针对炎症性疾病的靶向这些受体家族的治疗性化合物至关重要。TLR5 与其细菌配体鞭毛蛋白复合物的晶体结构揭示了 TLR5 的配体结合模式与其先前表征的 TLRs 不同。然而,与其他 TLR 一样,TLR5 在配体结合时形成二聚体。这项工作有助于我们目前对 TLR 功能的了解,并进一步证明了 TLR 能够将多样化的配体识别与保守的受体信号机制相耦合的能力。